Doctor profile · Federal record
Dr. Michael Lee, M.D.
Dermatology Physician (CMS: Dermatology) · San Diego, CA
- NPI 1255607685
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 14 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
3965 5Th Ave Ste 200
San Diego, CA 921033107
(619) 542-0013
fax (619) 542-0559
Credentials & registration
- NPI registered
- March 2012 — 14 yrs on file
- Profile last updated
- April 14, 2023
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- California #A128109
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1255607685. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,667
Distinct HCPCS
10
Medicare allowed
$164,501
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 2,800 | 13 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 744 | 106 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 316 | 221 | $97 | |
17000 |
Destruction of precancer skin growth, 1 growth | 169 | 129 | $57 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 142 | 105 | $137 | |
11102 |
Biopsy of related skin growth, first growth | 111 | 90 | $106 | |
17110 |
Destruction of skin growth, 1-14 growths | 97 | 84 | $123 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 90 | 59 | $189 | |
17311 |
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 37 | 32 | $694 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 36 | 36 | $120 |
In context: peer comparison
Among 44 peers in this city , average services per provider: 198. This provider delivers 24× the peer median.Open Payments
Industry payments received
All-time total
$5,720
Transactions
98
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $2,783.62 | |
| Dermavant Sciences, Inc. | 13 | $984.59 | |
| ABBVIE INC. | 15 | $346.51 | |
| Lilly USA, LLC | 11 | $303.50 | |
| PFIZER INC. | 14 | $260.32 | |
| UCB, Inc. | 8 | $230.53 | |
| GENZYME CORPORATION | 2 | $155.70 | |
| Regeneron Healthcare Solutions, Inc. | 6 | $128.59 | |
| Amgen Inc. | 4 | $98.27 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $79.21 | |
| Incyte Corporation | 3 | $73.89 | |
| Arcutis Biotherapeutics, Inc. | 3 | $69.57 | |
| Janssen Biotech, Inc. | 1 | $59.99 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $55.99 | |
| Almirall LLC | 2 | $52.08 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
320
Patients
211
Total drug cost
$15,029
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 75 | 35 | $1,829 |
| Gentamicin Sulfate | Generic | 72 | 61 | $1,753 |
| Triamcinolone Acetonide | Generic | 41 | 33 | $788 |
| Fluorouracil | Generic | 36 | 31 | $3,104 |
| Clobetasol Propionate | Generic | 23 | 15 | $3,421 |
| Fluocinonide | Generic | 19 | 12 | $633 |
| Doxycycline Monohydrate | Generic | 17 | 13 | $343 |
| Terbinafine Hcl | Generic | 15 | 11 | $327 |
| Mupirocin | Generic | 11 | 0 | $78 |
| Tacrolimus | Generic | 11 | 0 | $2,754 |
Frequently asked questions
What is Dr. Michael Lee's medical specialty?
Dr. Michael Lee practices Dermatology Physician in San Diego, CA.
Where does Dr. Michael Lee practice?
Dr. Michael Lee practices at 3965 5Th Ave Ste 200, San Diego, CA 921033107. Office phone: 6195420013.
What is Dr. Michael Lee's NPI?
Dr. Michael Lee's National Provider Identifier (NPI) is 1255607685, issued by NPPES.
Does Dr. Michael Lee accept Medicare assignment?
Yes. Dr. Michael Lee accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Lee commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.